Beach bound
Slip into a coastal state of mind�as you kick back, relax and discover your next beach escape. Your hammock awaits.

20 Devonshire Place, W1G 6BW, W1G Marylebone London
* More than 15 years of experience* Consultant Medical Oncologist, The London Clinic, Central London (present) * Consultant Medical Oncologist, Leaders in Oncology Care (LOC), Central London (present)* Consultant Medical Oncologist, University College London Hospitals NHS Foundation Trust (present)* Consultant Medical Oncologist, Princess Alexandra Hospital NHS Foundation Trust, Harlow (present) ...
* PhD Medical Oncology University of Crete (2012)* Degree in Medicine Athens University (2002)
* Royal College of Physicians* Medical Defence Union * General Medical Council ...
* ASCO (American Society of Clinical Oncology) Merit Award (2010)
* First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors,Clin Cancer Res . 2020 Sep 15;26(18):4777-4784* HyPeR: A phase 1, dose escalation and expansion trial of guadecitabine (SGI-110), a second-generation hypomethylating agent in combination with pembrolizumab (MK3475) in patients with refractory solid tumors, AACR Annual Meeting 2020; April 27-28, 2020 * Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit, Eur J Cancer . 2017 Apr;75:56-62* A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors, Clin Cancer Res . 2012 May 1;18(9):2687-94* Combining targeted therapeutics in the era of precision medicine, Br J Cancer 2015;112:1-3* Delayed onset immune related adverse effects (IRAEs) of pembrolizumab in non-small cell lung cancer, 2019, ESMO Annual Meeting, 1510P* A phase I study evaluating GDC-0941, an oral phosphoinositide-3 kinase (PI3K) inhibitor, in patients with advanced solid tumors or multiple myeloma, 2011 ASCO annual meeting* A first-in-human phase I study to evaluate the dual PI3K/mTOR inhibitor GDC-0980 administered QD in patients with advanced solid tumors or non-Hodgkin€™s lymphoma (NHL), 2010 ESMO annual meeting* Should patients with malignant intracranial space occupying lesions (M-ICSOLs) be excluded from phase I trials? The Royal Marsden Hospital Drug Development Unit experience. 2010 ASCO annual meeting 2010, received the ASCO foundation Merit Award. ...
* Lung cancer* Mesothelioma * Thymoma* Immunotherapy* Targeted therapies* Chemotherapy ...
* Lung cancer* Mesothelioma * Thymoma* Immunotherapy* Targeted therapies* Chemotherapy ...
Coupoly Medical Concierge Service
Coupoly Connects You To Doctors, Dentists And Hospitals.
Coupoly Private Healthcare team experienced with medical travel and healthcare professionals, passionate about the research, planning and delivery of International Healthcare options. We help you connect to a needed medical procedure or diagnostic.
Through Coupoly you can access Private Medical Services such as diagnostics, cancer treatments, spine surgery, hip and knee replacements, bariatric weight loss surgery, dental implants, Breast Surgery, Face Surgery, Hair Transplant and many other treatments- all without the wait.
At Coupoly we offer connections to a global network of medical specialists, plus:
Shop hotel and holiday rentals to find the perfect place to make new memories. By Expedia
Here�s where to go if you�re looking to plan a city break itinerary filled with the most memorable events and experiences. By Expedia
Expedia Hotel Deals